NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 46 filers reported holding NABRIVA THERAPEUTICS PLC in Q1 2018. The put-call ratio across all filers is 1.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $116,000 | -31.0% | 33,461 | 0.0% | 0.00% | – |
| Q1 2018 | $168,000 | -92.0% | 33,461 | -90.4% | 0.00% | -100.0% |
| Q4 2017 | $2,093,000 | -27.0% | 350,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $2,867,000 | -27.1% | 350,000 | 0.0% | 0.00% | -50.0% |
| Q2 2017 | $3,931,000 | – | 350,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 191,028 | $462,000 | 0.08% |
| Sterling Investment Advisors, Ltd. | 5,000 | $12,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |